Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED STATEMENTS OF CASH FLOWS

v3.25.0.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Cash flows from operating activities      
Net income (loss) $ 203,628 $ 150,757 $ 41,911
Adjustments to reconcile net income to net cash provided by operating activities:      
Provision for loss on receivables 1,059 11,832 12,798
Depreciation and amortization 1,003 3,127 3,993
Amortization of financing costs 17,039 12,958 11,685
Equity-based compensation 23,151 18,386 20,101
Equity method investments (179,747) (108,025) 16,403
Non-cash gain on sale or securitization (70,685) (43,542) (28,614)
(Gain) loss on sale of assets 7,299 1,305 (218)
Changes in receivables held-for-sale (29,273) 51,538 (62,953)
Loss on debt extinguishment 0 0 0
Changes in accounts payable, accrued expenses and other 101,410 48,485 18,176
Change in accrued interest on receivables and investments (78,639) (44,105) (15,414)
Cash received (paid) upon hedge settlement 20,311 0 0
Other (10,704) (3,027) (17,638)
Net cash provided by operating activities 5,852 99,689 230
Cash flows from investing activities      
Equity method investments (396,613) (869,412) (127,867)
Equity method investment distributions received 39,142 30,140 110,064
Proceeds from sales of equity method investments 9,472 0 1,700
Purchases of and investments in receivables (667,140) (1,338,860) (726,931)
Principal collections from receivables 600,652 197,784 125,976
Proceeds from sales of receivables 171,991 7,634 5,047
Purchases of real estate 0 0 (4,550)
Sales of real estate 115,767 0 4,550
Purchases of investments (10,537) (14,404) (2,329)
Proceeds from sales of investments and securitization assets 5,390 0 7,020
Collateral provided to hedge counterparties (27,090) (93,550) 0
Collateral received from hedge counterparties 27,570 84,950 0
Funding of escrow accounts 0 0 (5,476)
Withdrawal from escrow accounts 0 0 22,757
Other 204 2,915 (2,071)
Net cash provided by (used in) investing activities (131,192) (1,992,803) (592,110)
Cash flows from financing activities      
Proceeds from credit facilities 1,296,792 1,177,000 100,000
Principal payments on credit facilities (1,696,792) (827,000) (150,000)
Proceeds from (repayment of) commercial paper notes 70,000 30,000 (50,000)
Proceeds from issuance of term loan 250,000 365,000 383,000
Principal payments on term loan (567,952) (16,478) 0
Proceeds from issuance of senior unsecured notes 1,199,956 550,000 0
Redemption of senior unsecured notes (400,000) 0 0
Proceeds from issuance of convertible notes 0 402,500 200,000
Principal payments on convertible notes 0 (143,748) (461)
Purchase of capped calls related to the issuance of convertible notes 0 (37,835) 0
Net proceeds of common stock issuances 203,528 492,377 188,881
Payments of dividends and distributions (192,269) (159,786) (132,198)
Withholdings on employee share vesting (529) (1,488) (3,211)
Redemption premium paid 0 0 0
Payment of debt issuance costs (30,331) (22,894) (11,754)
Collateral provided to hedge counterparties (151,330) (166,600) 0
Collateral received from hedge counterparties 199,300 176,050 0
Other (969) (3,268) (9,820)
Net cash provided by (used in) financing activities 200,415 1,792,224 516,779
Increase (decrease) in cash, cash equivalents, and restricted cash 75,075 (100,890) (75,101)
Cash, cash equivalents, and restricted cash at beginning of period 75,082 175,972 251,073
Cash, cash equivalents, and restricted cash at end of period 150,157 75,082 175,972
Interest paid 192,960 138,418 98,704
Supplemental disclosure of non-cash activity      
Residual assets retained from securitization transactions 43,329 35,483 28,614
Equity method investments retained from securitization and deconsolidation transactions 32,564 144,603 0
Issuance of common stock from conversion of convertible notes 0 0 7,674
Equity method investments retained from sale of assets to co-investment structure 115,249 0 0
Deconsolidation of non-recourse debt and other liabilities 51,233 257,746 0
Deconsolidation of assets pledged for non-recourse debt 51,761 374,608 0
Assumption of deferred financing obligation 32,910 0 0
Non-recourse debt      
Cash flows from financing activities      
Proceeds from issuance of non-recourse debt 94,000 0 32,923
Principal payments on non-recourse debt $ (72,989) $ (21,606) $ (30,581)